BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9051775)

  • 1. Identification of planarian serotonin receptor by ligand binding and PCR studies.
    Saitoh O; Yuruzume E; Nakata H
    Neuroreport; 1996 Dec; 8(1):173-8. PubMed ID: 9051775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning and pharmacological characterisation of the guinea pig 5-ht5A receptor.
    Thomas DR; Larminie CG; Lyons HR; Fosberry A; Hill MJ; Hayes PD
    Eur J Pharmacol; 2004 Jun; 494(2-3):91-9. PubMed ID: 15212962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of a serotonin receptor (5-HT7) stimulating cAMP production in human corneal epithelial cells.
    Crider JY; Williams GW; Drace CD; Katoli P; Senchyna M; Sharif NA
    Invest Ophthalmol Vis Sci; 2003 Nov; 44(11):4837-44. PubMed ID: 14578406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
    Norman AB; Battaglia G; Creese I
    Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and radioligand binding characterization of rat 5-HT6 receptors stably expressed in HEK293 cells.
    Boess FG; Monsma FJ; Carolo C; Meyer V; Rudler A; Zwingelstein C; Sleight AJ
    Neuropharmacology; 1997; 36(4-5):713-20. PubMed ID: 9225298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-directed mutagenesis of the serotonin 5-hydroxytrypamine2 receptor: identification of amino acids necessary for ligand binding and receptor activation.
    Wang CD; Gallaher TK; Shih JC
    Mol Pharmacol; 1993 Jun; 43(6):931-40. PubMed ID: 8316224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a 5-HT receptor in locust nervous tissue.
    Wedemeyer S; Roeder T; Gewecke M
    Eur J Pharmacol; 1992 Nov; 223(2-3):173-8. PubMed ID: 1362163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular identification of a G protein-coupled receptor family which is expressed in planarians.
    Saitoh O; Yuruzume E; Watanabe K; Nakata H
    Gene; 1997 Aug; 195(1):55-61. PubMed ID: 9300820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS; Assié MB; Koek W
    J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.
    Monsma FJ; Shen Y; Ward RP; Hamblin MW; Sibley DR
    Mol Pharmacol; 1993 Mar; 43(3):320-7. PubMed ID: 7680751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of [3H]lysergic acid diethylamide binding to a 5-hydroxytryptamine receptor on human platelet membranes.
    Geaney DP; Schächter M; Elliot JM; Grahame-Smith DG
    Eur J Pharmacol; 1984 Jan; 97(1-2):87-93. PubMed ID: 6698111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
    Ransom RW; Asarch KB; Shih JC
    J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconsideration of 5-hydroxytryptamine (5-HT)(7) receptor distribution using [(3)H]5-carboxamidotryptamine and [(3)H]8-hydroxy-2-(di-n-propylamino)tetraline: analysis in brain of 5-HT(1A) knockout and 5-HT(1A/1B) double-knockout mice.
    Bonaventure P; Nepomuceno D; Kwok A; Chai W; Langlois X; Hen R; Stark K; Carruthers N; Lovenberg TW
    J Pharmacol Exp Ther; 2002 Jul; 302(1):240-8. PubMed ID: 12065723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning of a novel human serotonin receptor (5-HT7) positively linked to adenylate cyclase.
    Bard JA; Zgombick J; Adham N; Vaysse P; Branchek TA; Weinshank RL
    J Biol Chem; 1993 Nov; 268(31):23422-6. PubMed ID: 8226867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putative 5-ht5 receptors: localization in the mouse CNS and lack of effect in the inhibition of dural protein extravasation.
    Waeber C; Grailhe R; Yu XJ; Hen R; Moskowitz MA
    Ann N Y Acad Sci; 1998 Dec; 861():85-90. PubMed ID: 9928243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between low/high affinity ratios for 5-HT(1A) receptors and intrinsic activity.
    Assié MB; Cosi C; Koek W
    Eur J Pharmacol; 1999 Dec; 386(1):97-103. PubMed ID: 10611469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques.
    Nilsson T; Longmore J; Shaw D; Pantev E; Bard JA; Branchek T; Edvinsson L
    Eur J Pharmacol; 1999 May; 372(1):49-56. PubMed ID: 10374714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of LSD, ritanserin, 8-OH-DPAT, and lisuride on classical conditioning in the rabbit.
    Welsh SE; Kachelries WJ; Romano AG; Simansky KJ; Harvey JA
    Pharmacol Biochem Behav; 1998 Feb; 59(2):469-75. PubMed ID: 9476997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.